(NYSE: SOLV) Solventum's forecast annual revenue growth rate of 0.13% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.18%.
Solventum's revenue in 2025 is $8,308,000,000.On average, 16 Wall Street analysts forecast SOLV's revenue for 2025 to be $1,455,730,725,708, with the lowest SOLV revenue forecast at $1,317,320,388,108, and the highest SOLV revenue forecast at $1,547,081,548,524. On average, 16 Wall Street analysts forecast SOLV's revenue for 2026 to be $1,409,363,262,612, with the lowest SOLV revenue forecast at $1,303,825,380,192, and the highest SOLV revenue forecast at $1,539,641,992,878.
In 2027, SOLV is forecast to generate $1,462,132,203,822 in revenue, with the lowest revenue forecast at $1,376,144,781,588 and the highest revenue forecast at $1,582,376,184,612.